Fact Based List:
KPMG: Ten Imperatives for Pharmaceutical Commercial Transformation
Submitted by Clive Riddle on Mon, 08/10/2015 - 10:45
- Use commercial tactics, not clinical data, to differentiate new products
- Elevate pricing and contracting within the organization
- Take a more holistic approach to stakeholder mapping and prioritization
- Base sales models on a collaborative approach to improving outcomes
- Play a larger role in the industry transformation from “volume to value”
- Support providers in improving quality and patient satisfaction
- Leverage data and analytics to enhance commercial strategies
- Allocate commercial resources optimally across markets and brands
- Evolve performance metrics and incentives to reflect new realities
- Drive the transformation agenda throughout the enterprise
Source: KPMG: Change in pharma? Not optional; 10 Integrated imperatives for pharmaceutical commercial transformation.
Source URL: http://www.kpmg-institutes.com/content/dam/kpmg/healthcareli...
List Ratings: |
Lists You Might Also Be Interested In
- 5 Specialty Pharmaceutical Trends
- 2012 Access to Medicine Index Ranking of Top 20 Pharmaceutical Companies by Access to Medicine Activities
- Projected Top Five pharmaceutical products worldwide by revenue in 2017 ($USD billions)
- Top Five Pharmaceutical Companies by Sales and R&D Spending (2020 $US Dollars)
- Top 15 Pharmaceutical Corporations by U.S. Dispensed Prescriptions - 2009
Login or register to post comments